Yuno Akira 湯野晃

Researcher Number	40738473
Other IDs
Affiliation (based on the past Project Information) *help	2014 – 2016: 熊本大学, 医学部附属病院, 医員
Review Section/Research Field	Principal Investigator Surgical dentistry / Immunology
Keywords	Principal Investigator がんワクチン研究 / 癌免疫療法 / ペプチドワクチン療法 / 腫瘍免疫 / ヘルパーT細胞 / キラーT細胞 / がんペプチドワクチン療法

キラーT細胞とヘルパーT細胞を活性化する、がんペプチドワクチンの臨床応用Principal Investigator
- Principal Investigator
  
  湯野晃
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Immunology
- Research Institution
  Kumamoto University
Development of cancer peptide vaccine that can induce tumor-specific CTLs and Th cells.Principal Investigator
- Principal Investigator
  
  Yuno Akira
- Project Period (FY)
  2014 – 2015
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Research Field
  
  Surgical dentistry
- Research Institution
  Kumamoto University

All 2016 2015 Other

All Journal Article Presentation

[Journal Article] Generation of Large Numbers of Antigen-Expressing Human Dendritic Cells Using CD14-ML Technology2016
- Author(s)
  Imamura Y, Haruta M, Tomita Y, Matsumura K, Ikeda T, Yuno A, Hirayama M, Mizuta H, Nishimura Y, Senju S.
- Journal Title
  
  PLoS One.
  
  Volume: 11
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26893206
[Journal Article] Identification of Glypican-3-Derived Long Peptides Activating both CD8+ and CD4+ T-cells; Prolonged Overall Survival in Cancer Patients with Th Cell Response.2015
- Author(s)
  Mohammad Abu Sayem, Tomita Y, Yuno A, Hirayama M, Irie A, Tsukamoto H, Senju S, Yuba E, Yoshikawa T, Kono K, Nakatsura T, Nishimura Y.
- Journal Title
  
  Oncoimmunology.
  
  Volume: 5
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26893206
[Journal Article] Cancer immunotherapy using novel tumor-associated antigenic peptides identified by genome-wide cDNA microarray analyses2015
- Author(s)
  Nishimura, Y., Tomita, Y., Yuno, A., Yoshitake, Y., Shinohara, M.
- Journal Title
  
  Cancer Science
  
  Volume: 106 Issue: 5 Pages: 505-511
- DOI
  10.1111/cas.12650
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PLANNED-22133005, KAKENHI-PROJECT-15H04311, KAKENHI-PROJECT-26893206, KAKENHI-PROJECT-25463113
[Journal Article] Phase II clinical trial of multiple peptide vaccination for advanced head and neck cancer patients revealed induction of immune responses and improved OS.2015
- Author(s)
  Yoshitake , Y., Fukuma, D., Yuno, A. , Hirayama, M. , Nakayama, H. , Tanaka. T., Nagata, M. , Takamune, Y., Kawahara, K., Nakagawa, Y., Yoshida, R., Hirosue, A., Ogi, H., Hiraki, A. , Jono, H., Hamada, A., Yoshida, K., Nishimura, Y., Nakamura, Y., and Shinohara, M
- Journal Title
  
  Clin. Cancer Res.
  
  Volume: 21 Pages: 312-321
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-26893206
[Presentation] Identification of promiscuous oncofetal antigen (IMP-3)-derived long peptides, bearing both Th cells and CTL epitopes2015
- Author(s)
  Hirayama Masatoshi, Tomita Yusuke, Yuno Akira, Mohammad Abu Sayem, Tsukamoto Hirotake, Irie Atsushi, Senju Satoru, Yoshitake Yoshihiro, Fukuma Daiki, Shinohara Masanori , Yuba Eiji, Kono Kenji, Yoshida Koji, Nakamura Yusuke, Nakayama Hideki and Nishimura Yasuharu
- Organizer
  American Association for Cancer research (AACR) Annual Meeting 2015
- Place of Presentation
  フィラデルフィア
- Year and Date
  2015-04-18
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26893206
[Presentation] Identification of IMP-3-derived multiple HLA class II-restricted long peptides that can activate both CTLs and Th cells2015
- Author(s)
  Hirayama Masatoshi, Tomita Yusuke, Yuno Akira, Mohammad Abu Sayem, Tsukamoto Hirotake, Senju Satoru, Fukuma Daiki, Yuba Eiji, Kono Kenji, Yoshida Koji, Nakamura Yusuke, Nakayama Hideki and Nishimura Yasuharu
- Organizer
  第74回日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-26893206
[Presentation] Tumor-associated antigen-specific CD4+ T-cell immunity augmented by CTL-epitopes vaccination in patients with malignant tumor
- Author(s)
  Yuno Akira, Tomita Yusuke, Hirayama Masatoshi, Fukuma Daiki, Yoshitake Yoshihiro, Ogi Hidenao, Nakayama Hideki, Hiraki Akimitsu, Tsunoda Takuya, Daigo Yataro, Nakamura Yusuke, Nishimura Yasuharu, Shinohara Masanori
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-26893206
[Presentation] 腫瘍関連抗原特異的なCTLとTh1細胞を活性化する、がんペプチドワクチン療法の開発
- Author(s)
  湯野晃、冨田雄介、平山真敏、福間大喜、吉武義泰、中山秀樹、平木昭光、中村祐輔、西村泰治、篠原正徳
- Organizer
  第59回日本口腔外科学会総会
- Place of Presentation
  千葉
- Year and Date
  2014-10-17 – 2014-10-19
- Data Source
  KAKENHI-PROJECT-26893206
[Presentation] 新規癌精巣抗原KIF-20A由来のCTLとTh1細胞を活性化する、がんペプチドワクチンの同定
- Author(s)
  湯野晃、冨田雄介、平山真敏、福間大喜、吉武義泰、尾木秀直、中山秀樹、平木昭光、中村祐輔、西村泰治、篠原正徳
- Organizer
  第33回日本口腔腫瘍学会総会
- Place of Presentation
  奈良
- Year and Date
  2015-01-29 – 2015-01-30
- Data Source
  KAKENHI-PROJECT-26893206

1. 西村康治

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Yuno Akira 湯野 晃

Research Projects

Research Products

Co-Researchers

キラーT細胞とヘルパーT細胞を活性化する、がんペプチドワクチンの臨床応用Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of cancer peptide vaccine that can induce tumor-specific CTLs and Th cells.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Generation of Large Numbers of Antigen-Expressing Human Dendritic Cells Using CD14-ML Technology2016

Author(s)

Journal Title

Data Source

[Journal Article] Identification of Glypican-3-Derived Long Peptides Activating both CD8+ and CD4+ T-cells; Prolonged Overall Survival in Cancer Patients with Th Cell Response.2015

Author(s)

Journal Title

Data Source

[Journal Article] Cancer immunotherapy using novel tumor-associated antigenic peptides identified by genome-wide cDNA microarray analyses2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Phase II clinical trial of multiple peptide vaccination for advanced head and neck cancer patients revealed induction of immune responses and improved OS.2015

Author(s)

Journal Title

Data Source

[Presentation] Identification of promiscuous oncofetal antigen (IMP-3)-derived long peptides, bearing both Th cells and CTL epitopes2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Identification of IMP-3-derived multiple HLA class II-restricted long peptides that can activate both CTLs and Th cells2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Tumor-associated antigen-specific CD4+ T-cell immunity augmented by CTL-epitopes vaccination in patients with malignant tumor

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 腫瘍関連抗原特異的なCTLとTh1細胞を活性化する、がんペプチドワクチン療法の開発

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] 新規癌精巣抗原KIF-20A由来のCTLとTh1細胞を活性化する、がんペプチドワクチンの同定

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

Yuno Akira 湯野晃